Loading...
Loading...
Contributors:
Dataset URI:
de95fc8e-e83a-4de3-bcd4-a00f172f3eddBackground: The purpose of this study was to conduct clinical trials on multiple new diagnostic devices in diverse populations and settings in the United States using a platform trial design. Specifically, these prospective clinical trials sought to validate devices used in the detection of SARS-CoV-2. Materials/Methods: Performance was examined of the 2183 device (a and b), a lateral flow immunoassay for the point-of-care (POC) detection of SARS-CoV-2 nucleocapsid protein antigen, compared to the Roche 6800 Cobas PCR for SARS-CoV-2 assay. Testing was done to determine the percent positive (sensitivity) and percent negative (specificity) agreement of the device in detecting COVID-19 (or SARS CoV-2) in symptomatic and asymptomatic people of all ages. No device performance data were included in the data files. Clinical questionnaires and surveys were administered to the participants. Outcome/Impact: The outcome was for Emergency Use Authorization (EUA) approval for the 2183 device to be used among symptomatic persons by trained healthcare personnel that collected specimens for SARS CoV-2 detection.
Keyword(s):
COVID-19; N/A.
MeSH Term(s):
Grants and Funding:
Associated Publication(s):
No Associated Publication Data Available
Supplementary Data:
No Supplementary Data Available
Related Dataset(s):
No Related Dataset Data Available
The National Library of Medicine (NLM) provides information about biomedical datasets. Inclusion on an NLM Web page does not imply endorsement of, or agreement with, the contents by NLM or the National Institutes of Health. Learn more: NLM Web Policies (nih.gov)